TapewireFind a company

person · Reporting owner

Jacobs Ian Seth

Disclosed activity across 18 companies

Tapewire entity
29526
SEC CIK
0001707297

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Aeluma, Inc.N/A · Entity 6202Former Director and OfficerJune 22, 2021June 24, 2021
Amesite Inc.NONE · Entity 149985Director · President,Secretary,CEO & CFOAugust 26, 2017May 01, 2018
Augmedix, Inc.NONE · Entity 86996Former Director and OfficerOctober 05, 2020October 07, 2020
Compass Therapeutics, Inc.NONE · Entity 5614Director · President, Sec, CEO, & CFOJuly 29, 2018July 30, 2018
DEEP FISSION, INC.NONE · Entity 5748Director · President, CEO, CFO, SecretaryAugust 26, 2025August 28, 2025
Deep Isolation Nuclear, Inc.NONE · Entity 9903Director · President, CEO, CFO, SecretaryJuly 16, 2025July 18, 2025
EXICURE, INC.NONE · Entity 8068Director · President, Secretary, CEO, CFOSeptember 22, 2017September 26, 2017
Guerrilla RF, Inc.NONE · Entity 7285Director · President, CEO, CFO, SecretaryMarch 05, 2021July 14, 2021
Margaree Acquisition Corp.NONE · Entity 29500Director · President, CEO, CFO, Secretary · 10% ownerJuly 17, 2026July 20, 2026
Orielle Acquisition Corp.NONE · Entity 75992Director · President, CEO, CFO, SecretaryAugust 26, 2025August 28, 2025
Primus Acquisition Inc.NONE · Entity 68795Director · President, CEO, CFO, SecretaryJanuary 26, 2026January 27, 2026
Range Acquisition Corp.NONE · Entity 72416Director · President, CEO, CFO, SecretaryDecember 01, 2025December 02, 2025
Var Acquisition Corp.NONE · Entity 74862Director · President, CEO, CFO, SecretarySeptember 30, 2025September 30, 2025

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Aeluma, Inc.

Report date June 22, 2021 · Filed June 24, 2021

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common stock, par value $0.0001 per shareSEC Table I · non-derivativeDirect200,000 Reported balance After 2021-06-22 transaction · row 1
1 source row

Row 1 · 2021-06-22 · Other · Disposed 50,000 · Balance 200,000

F1: Pursuant to the terms of an Agreement and Plan of Merger and Reorganization, dated as of June 22, 2021, by and among the Issuer, Aeluma Operating Co. ("Acquisition Sub"), and Biond Photonics, Inc. (d.b.a. "Aeluma") ("Biond"), on June 22, 2021, Biond merged with and into Acquisition Sub, with Acquisition Sub continuing as the surviving entity (the "Merger") and as the Issuer's wholly-owned subsidiary. As a condition to the Merger, pursuant to the terms of a stock cancellation agreement, the reporting person voluntarily surrendered and canceled 50,000 shares of the Issuer's common stock prior to the consummation of the Merger. The reporting person resigned as a director and officer of the Issuer upon consummation of the Merger.

Filing footnotes · ownership attribution and instrument terms

F1: Pursuant to the terms of an Agreement and Plan of Merger and Reorganization, dated as of June 22, 2021, by and among the Issuer, Aeluma Operating Co. ("Acquisition Sub"), and Biond Photonics, Inc. (d.b.a. "Aeluma") ("Biond"), on June 22, 2021, Biond merged with and into Acquisition Sub, with Acquisition Sub continuing as the surviving entity (the "Merger") and as the Issuer's wholly-owned subsidiary. As a condition to the Merger, pursuant to the terms of a stock cancellation agreement, the reporting person voluntarily surrendered and canceled 50,000 shares of the Issuer's common stock prior to the consummation of the Merger. The reporting person resigned as a director and officer of the Issuer upon consummation of the Merger.

Amesite Inc.

Report date August 26, 2017 · Filed May 01, 2018

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common Stock, par value $0.0001 per shareSEC Table I · non-derivativeDirect199,333 Reported balance Holding disclosure · report date 2017-08-26 · row 1 Holding and transaction disclosures are not merged.
1 source row

Row 1 · Balance 199,333

F1: Reflects the forward stock split of the Company's outstanding common stock at a ratio of 3.066668-for-1, effective as of March 27, 2018.

Filing footnotes · ownership attribution and instrument terms

F1: Reflects the forward stock split of the Company's outstanding common stock at a ratio of 3.066668-for-1, effective as of March 27, 2018.

Augmedix, Inc.

Report date October 05, 2020 · Filed October 07, 2020

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common stock, par value $0.0001 per shareSEC Table I · non-derivativeDirect160,000 Reported balance After 2020-10-05 transaction · row 1
1 source row

Row 1 · 2020-10-05 · Other · Disposed 90,000 · Balance 160,000

F1: Pursuant to the terms of an Agreement and Plan of Merger and Reorganization, dated as of October 5, 2020, by and among the Issuer, August Acquisition Corp. ("Acquisition Sub"), and Augmedix Operating Company (f/k/a Augmedix, Inc.) ("Augmedix"), on October 5, 2020, Acquisition Sub merged with and into Augmedix, with Augmedix continuing as the surviving entity (the "Merger") and as the Issuer's wholly-owned subsidiary. As a condition to the Merger, pursuant to the terms of a stock cancellation agreement, the reporting person voluntarily surrendered and canceled 90,000 shares of the Issuer's common stock prior to the consummation of the Merger. The reporting person resigned as a director and officer of the Issuer upon consummation of the Merger

Filing footnotes · ownership attribution and instrument terms

F1: Pursuant to the terms of an Agreement and Plan of Merger and Reorganization, dated as of October 5, 2020, by and among the Issuer, August Acquisition Corp. ("Acquisition Sub"), and Augmedix Operating Company (f/k/a Augmedix, Inc.) ("Augmedix"), on October 5, 2020, Acquisition Sub merged with and into Augmedix, with Augmedix continuing as the surviving entity (the "Merger") and as the Issuer's wholly-owned subsidiary. As a condition to the Merger, pursuant to the terms of a stock cancellation agreement, the reporting person voluntarily surrendered and canceled 90,000 shares of the Issuer's common stock prior to the consummation of the Merger. The reporting person resigned as a director and officer of the Issuer upon consummation of the Merger

Compass Therapeutics, Inc.

Report date July 29, 2018 · Filed July 30, 2018

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common Stock, par value $0.0001SEC Table I · non-derivativeDirect250,000 Reported balance Holding disclosure · report date 2018-07-29 · row 1 Holding and transaction disclosures are not merged.
1 source row

Row 1 · Balance 250,000

DEEP FISSION, INC.

Report date August 26, 2025 · Filed August 28, 2025

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect275,000 Reported balance After 2025-08-26 transaction · row 1
1 source row

Row 1 · 2025-08-26 · Purchase · Acquired 25,000 · Balance 275,000

Deep Isolation Nuclear, Inc.

Report date July 16, 2025 · Filed July 18, 2025

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect275,000 Reported balance After 2025-07-16 transaction · row 1
1 source row

Row 1 · 2025-07-16 · Purchase · Acquired 25,000 · Balance 275,000

EXICURE, INC.

Report date September 22, 2017 · Filed September 26, 2017

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect103,160 Reported balance After 2017-09-22 transaction · row 1
1 source row

Row 1 · 2017-09-22 · Grant · Acquired 38,160 · Balance 103,160

F1: These shares were received for services rendered in connection with a proposed merger among the issuer, Exicure, Inc., and Max-1 Acquisition Sub, Inc., a wholly owned subsidiary of the issuer.

Filing footnotes · ownership attribution and instrument terms

F1: These shares were received for services rendered in connection with a proposed merger among the issuer, Exicure, Inc., and Max-1 Acquisition Sub, Inc., a wholly owned subsidiary of the issuer.

Guerrilla RF, Inc.

Report date March 05, 2021 · Filed July 14, 2021

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect250,000 Reported balance Holding disclosure · report date 2021-03-05 · row 1 Holding and transaction disclosures are not merged.
1 source row

Row 1 · Balance 250,000

Margaree Acquisition Corp.

Report date July 17, 2026 · Filed July 20, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect2,500,000 Reported balance Holding disclosure · report date 2026-07-17 · row 1 Holding and transaction disclosures are not merged.
1 source row

Row 1 · Balance 2,500,000

Orielle Acquisition Corp.

Report date August 26, 2025 · Filed August 28, 2025

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect325,000 Reported balance After 2025-08-26 transaction · row 1
1 source row

Row 1 · 2025-08-26 · Purchase · Acquired 50,000 · Balance 325,000

Primus Acquisition Inc.

Report date January 26, 2026 · Filed January 27, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect2,500,000 Reported balance Holding disclosure · report date 2026-01-26 · row 1 Holding and transaction disclosures are not merged.
1 source row

Row 1 · Balance 2,500,000

Range Acquisition Corp.

Report date December 01, 2025 · Filed December 02, 2025

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect2,500,000 Reported balance Holding disclosure · report date 2025-12-01 · row 1 Holding and transaction disclosures are not merged.
1 source row

Row 1 · Balance 2,500,000

Var Acquisition Corp.

Report date September 30, 2025 · Filed September 30, 2025

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect2,500,000 Reported balance Holding disclosure · report date 2025-09-30 · row 1 Holding and transaction disclosures are not merged.
1 source row

Row 1 · Balance 2,500,000

Past disclosures · reporting ended (5)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Lomond Therapeutics Holdings, Inc.

Report date November 01, 2024 · Filed November 05, 2024

Section 16 reporting ended · disclosed 2024-11-05. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect175,000 Reported balance After 2024-11-01 transaction · row 1
1 source row

Row 1 · 2024-11-01 · Other · Disposed 75,000 · Balance 175,000

F1: As a condition under the terms of an Agreement and Plan of Merger and Reorganization, dated as of November 1, 2024, and pursuant to the terms of a stock cancellation agreement, the reporting person voluntarily surrendered and cancelled for no consideration 75,000 shares of Issuer's common stock prior to the consummation of the Merger on November 1, 2024. The reporting person resigned as a director and officer of the Issuer upon consummation of the Merger.

Filing footnotes · ownership attribution and instrument terms

F1: As a condition under the terms of an Agreement and Plan of Merger and Reorganization, dated as of November 1, 2024, and pursuant to the terms of a stock cancellation agreement, the reporting person voluntarily surrendered and cancelled for no consideration 75,000 shares of Issuer's common stock prior to the consummation of the Merger on November 1, 2024. The reporting person resigned as a director and officer of the Issuer upon consummation of the Merger.

Matternet, Inc.

Report date May 22, 2026 · Filed May 28, 2026

Section 16 reporting ended · disclosed 2026-05-28. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect325,000 Reported balance After 2026-05-22 transaction · row 1
1 source row

Row 1 · 2026-05-22 · Other · Disposed 2,175,000 · Balance 325,000

F1: As a condition under the terms of an Agreement and Plan of Merger and Reorganization, dated May 22, 2026 (the merger contemplated under such agreement, "Merger"), and pursuant to the terms of a stock cancellation agreement, the reporting person voluntarily surrendered and cancelled, for no consideration, 2,175,000 shares of the Issuer's common stock prior to the consummation of the Merger on May 22, 2026 ("Closing Date"). The reporting person resigned as the President, Chief Executive Officer, Chief Financial Officer, Director, and Secretary of the Issuer upon consummation of the Merger.

Filing footnotes · ownership attribution and instrument terms

F1: As a condition under the terms of an Agreement and Plan of Merger and Reorganization, dated May 22, 2026 (the merger contemplated under such agreement, "Merger"), and pursuant to the terms of a stock cancellation agreement, the reporting person voluntarily surrendered and cancelled, for no consideration, 2,175,000 shares of the Issuer's common stock prior to the consummation of the Merger on May 22, 2026 ("Closing Date"). The reporting person resigned as the President, Chief Executive Officer, Chief Financial Officer, Director, and Secretary of the Issuer upon consummation of the Merger.

Serve Robotics Inc. /DE/

Report date July 31, 2023 · Filed August 03, 2023

Section 16 reporting ended · disclosed 2023-08-03. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect125,000 Reported balance After 2023-07-31 transaction · row 1
1 source row

Row 1 · 2023-07-31 · Other · Disposed 125,000 · Balance 125,000

F1: As a condition under the terms of an Agreement and Plan of Merger and Reorganization, dated as of July 31, 2023, and pursuant to the terms of a stock cancellation agreement, the reporting person voluntarily surrendered and cancelled for no consideration 125,000 shares of Issuer's common stock prior to the consummation of the merger. The reporting person resigned as an officer and director of the Issuer upon consummation of the merger.

Filing footnotes · ownership attribution and instrument terms

F1: As a condition under the terms of an Agreement and Plan of Merger and Reorganization, dated as of July 31, 2023, and pursuant to the terms of a stock cancellation agreement, the reporting person voluntarily surrendered and cancelled for no consideration 125,000 shares of Issuer's common stock prior to the consummation of the merger. The reporting person resigned as an officer and director of the Issuer upon consummation of the merger.

SmartKem, Inc.

Report date February 23, 2021 · Filed February 26, 2021

Section 16 reporting ended · disclosed 2021-02-26. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common Stock, par value $0.0001SEC Table I · non-derivativeDirect200,000 Reported balance After 2021-02-23 transaction · row 1
1 source row

Row 1 · 2021-02-23 · Other · Disposed 50,000 · Balance 200,000

F1: Pursuant to the terms of a Share Exchange Agreement, dated as of February 23, 2021, by and among the Issuer, SmartKem Inc. (f/k/a SmartKem Limited) ("SmartKem"), and the former shareholders of SmartKem, on February 23, 2021, all of the equity interests in SmartKem, except certain "deferred shares," exchanged for shares of Issuer's common stock, with SmartKem continuing as the Issuer's wholly owned subsidiary (the "Exchange"). As a condition to the Exchange, pursuant to the terms of a stock cancellation agreement, the reporting person voluntarily surrendered and canceled 50,000 shares of the Issuer's common stock prior to the consummation of the Exchange. The reporting person resigned as a director and officer of the Issuer upon consummation of the Exchange.

Filing footnotes · ownership attribution and instrument terms

F1: Pursuant to the terms of a Share Exchange Agreement, dated as of February 23, 2021, by and among the Issuer, SmartKem Inc. (f/k/a SmartKem Limited) ("SmartKem"), and the former shareholders of SmartKem, on February 23, 2021, all of the equity interests in SmartKem, except certain "deferred shares," exchanged for shares of Issuer's common stock, with SmartKem continuing as the Issuer's wholly owned subsidiary (the "Exchange"). As a condition to the Exchange, pursuant to the terms of a stock cancellation agreement, the reporting person voluntarily surrendered and canceled 50,000 shares of the Issuer's common stock prior to the consummation of the Exchange. The reporting person resigned as a director and officer of the Issuer upon consummation of the Exchange.

Transphorm, Inc.

Report date February 12, 2020 · Filed February 14, 2020

Section 16 reporting ended · disclosed 2020-02-14. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common Stock, par value $0.0001SEC Table I · non-derivativeDirect125,000 Reported balance After 2020-02-12 transaction · row 1
1 source row

Row 1 · 2020-02-12 · Other · Disposed 25,000 · Balance 125,000

F1: Pursuant to the terms and conditions of that certain Agreement and Plan of Merger and Reorganization, dated as of February 12, 2020, by and among Transphorm, Inc., f/k/a Peninsula Acquisition Corporation (the "Issuer"), Peninsula Acquisition Sub, Inc. ("Acquisition Sub"), and Transphorm Technology, Inc., f/k/a Transphorm, Inc. ("Transphorm"), on February 12, 2020, Acquisition Sub merged with and into Transphorm, with Transphorm continuing as the surviving entity (the "Merger") and as the Issuer's wholly-owned subsidiary. Pursuant to the terms of a stock forfeiture letter, the reporting person forfeited and canceled 25,000 shares of the Issuer's common stock immediately prior to the consummation of the Merger.

Filing footnotes · ownership attribution and instrument terms

F1: Pursuant to the terms and conditions of that certain Agreement and Plan of Merger and Reorganization, dated as of February 12, 2020, by and among Transphorm, Inc., f/k/a Peninsula Acquisition Corporation (the "Issuer"), Peninsula Acquisition Sub, Inc. ("Acquisition Sub"), and Transphorm Technology, Inc., f/k/a Transphorm, Inc. ("Transphorm"), on February 12, 2020, Acquisition Sub merged with and into Transphorm, with Transphorm continuing as the surviving entity (the "Merger") and as the Issuer's wholly-owned subsidiary. Pursuant to the terms of a stock forfeiture letter, the reporting person forfeited and canceled 25,000 shares of the Issuer's common stock immediately prior to the consummation of the Merger.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
May 22, 2026 Filed May 28, 2026 00:46 UTC Matternet, Inc. NONE · Entity 26314 OtherCommon Stock 2,175,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-061677 · ownership.xml · nonDerivative · entry 1

Jacobs Ian Seth · CIK 0001707297 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 325,000

F1 · kind: As a condition under the terms of an Agreement and Plan of Merger and Reorganization, dated May 22, 2026 (the merger contemplated under such agreement, "Merger"), and pursuant to the terms of a stock cancellation agreement, the reporting person voluntarily surrendered and cancelled, for no consideration, 2,175,000 shares of the Issuer's common stock prior to the consummation of the Merger on May 22, 2026 ("Closing Date"). The reporting person resigned as the President, Chief Executive Officer, Chief Financial Officer, Director, and Secretary of the Issuer upon consummation of the Merger.

F1 · price: As a condition under the terms of an Agreement and Plan of Merger and Reorganization, dated May 22, 2026 (the merger contemplated under such agreement, "Merger"), and pursuant to the terms of a stock cancellation agreement, the reporting person voluntarily surrendered and cancelled, for no consideration, 2,175,000 shares of the Issuer's common stock prior to the consummation of the Merger on May 22, 2026 ("Closing Date"). The reporting person resigned as the President, Chief Executive Officer, Chief Financial Officer, Director, and Secretary of the Issuer upon consummation of the Merger.

Read SEC document
August 26, 2025 Filed Aug 28, 2025 23:00 UTC DEEP FISSION, INC. NONE · Entity 5748 PurchaseCommon Stock 25,000 $0.00 $2.50
Disclosure

SEC source: 0001213900-25-081956 · ownership.xml · nonDerivative · entry 1

Jacobs Ian Seth · CIK 0001707297 · Director · President, CEO, CFO, Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 275,000

Read SEC document
August 26, 2025 Filed Aug 28, 2025 23:02 UTC Orielle Acquisition Corp. NONE · Entity 75992 PurchaseCommon Stock 50,000 $0.00 $5.00
Disclosure

SEC source: 0001213900-25-081958 · ownership.xml · nonDerivative · entry 1

Jacobs Ian Seth · CIK 0001707297 · Director · President, CEO, CFO, Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 325,000

Read SEC document
July 16, 2025 Filed Jul 18, 2025 22:08 UTC Deep Isolation Nuclear, Inc. NONE · Entity 9903 PurchaseCommon Stock 25,000 $0.00 $2.50
Disclosure

SEC source: 0001213900-25-065807 · ownership.xml · nonDerivative · entry 1

Jacobs Ian Seth · CIK 0001707297 · Director · President, CEO, CFO, Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 275,000

Read SEC document
November 01, 2024 Filed Nov 5, 2024 23:33 UTC Lomond Therapeutics Holdings, Inc. NONE · Entity 86303 OtherCommon Stock 75,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-24-094680 · ownership.xml · nonDerivative · entry 1

Jacobs Ian Seth · CIK 0001707297 · Former Director and officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 175,000

F1 · kind: As a condition under the terms of an Agreement and Plan of Merger and Reorganization, dated as of November 1, 2024, and pursuant to the terms of a stock cancellation agreement, the reporting person voluntarily surrendered and cancelled for no consideration 75,000 shares of Issuer's common stock prior to the consummation of the Merger on November 1, 2024. The reporting person resigned as a director and officer of the Issuer upon consummation of the Merger.

F1 · price: As a condition under the terms of an Agreement and Plan of Merger and Reorganization, dated as of November 1, 2024, and pursuant to the terms of a stock cancellation agreement, the reporting person voluntarily surrendered and cancelled for no consideration 75,000 shares of Issuer's common stock prior to the consummation of the Merger on November 1, 2024. The reporting person resigned as a director and officer of the Issuer upon consummation of the Merger.

Read SEC document
July 31, 2023 Filed Aug 3, 2023 01:49 UTC Serve Robotics Inc. /DE/ NONE · Entity 5633 OtherCommon Stock 125,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-23-062753 · ownership.xml · nonDerivative · entry 1

Jacobs Ian Seth · CIK 0001707297 · Former Director and Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,000

F1 · kind: As a condition under the terms of an Agreement and Plan of Merger and Reorganization, dated as of July 31, 2023, and pursuant to the terms of a stock cancellation agreement, the reporting person voluntarily surrendered and cancelled for no consideration 125,000 shares of Issuer's common stock prior to the consummation of the merger. The reporting person resigned as an officer and director of the Issuer upon consummation of the merger.

F1 · price: As a condition under the terms of an Agreement and Plan of Merger and Reorganization, dated as of July 31, 2023, and pursuant to the terms of a stock cancellation agreement, the reporting person voluntarily surrendered and cancelled for no consideration 125,000 shares of Issuer's common stock prior to the consummation of the merger. The reporting person resigned as an officer and director of the Issuer upon consummation of the merger.

Read SEC document
June 22, 2021 Filed Jun 24, 2021 01:51 UTC Aeluma, Inc. N/A · Entity 6202 OtherCommon stock, par value $0.0001 per share 50,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-21-033882 · ownership.xml · nonDerivative · entry 1

Jacobs Ian Seth · CIK 0001707297 · Former Director and Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

F1 · kind: Pursuant to the terms of an Agreement and Plan of Merger and Reorganization, dated as of June 22, 2021, by and among the Issuer, Aeluma Operating Co. ("Acquisition Sub"), and Biond Photonics, Inc. (d.b.a. "Aeluma") ("Biond"), on June 22, 2021, Biond merged with and into Acquisition Sub, with Acquisition Sub continuing as the surviving entity (the "Merger") and as the Issuer's wholly-owned subsidiary. As a condition to the Merger, pursuant to the terms of a stock cancellation agreement, the reporting person voluntarily surrendered and canceled 50,000 shares of the Issuer's common stock prior to the consummation of the Merger. The reporting person resigned as a director and officer of the Issuer upon consummation of the Merger.

F1 · price: Pursuant to the terms of an Agreement and Plan of Merger and Reorganization, dated as of June 22, 2021, by and among the Issuer, Aeluma Operating Co. ("Acquisition Sub"), and Biond Photonics, Inc. (d.b.a. "Aeluma") ("Biond"), on June 22, 2021, Biond merged with and into Acquisition Sub, with Acquisition Sub continuing as the surviving entity (the "Merger") and as the Issuer's wholly-owned subsidiary. As a condition to the Merger, pursuant to the terms of a stock cancellation agreement, the reporting person voluntarily surrendered and canceled 50,000 shares of the Issuer's common stock prior to the consummation of the Merger. The reporting person resigned as a director and officer of the Issuer upon consummation of the Merger.

Read SEC document
February 23, 2021 Filed Feb 26, 2021 02:44 UTC SmartKem, Inc. NONE · Entity 8554 OtherCommon Stock, par value $0.0001 50,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-21-028484 · tm217635-1_4seq1.xml · nonDerivative · entry 1

Jacobs Ian Seth · CIK 0001707297 · Former Officer and Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

F1 · kind: Pursuant to the terms of a Share Exchange Agreement, dated as of February 23, 2021, by and among the Issuer, SmartKem Inc. (f/k/a SmartKem Limited) ("SmartKem"), and the former shareholders of SmartKem, on February 23, 2021, all of the equity interests in SmartKem, except certain "deferred shares," exchanged for shares of Issuer's common stock, with SmartKem continuing as the Issuer's wholly owned subsidiary (the "Exchange"). As a condition to the Exchange, pursuant to the terms of a stock cancellation agreement, the reporting person voluntarily surrendered and canceled 50,000 shares of the Issuer's common stock prior to the consummation of the Exchange. The reporting person resigned as a director and officer of the Issuer upon consummation of the Exchange.

F1 · price: Pursuant to the terms of a Share Exchange Agreement, dated as of February 23, 2021, by and among the Issuer, SmartKem Inc. (f/k/a SmartKem Limited) ("SmartKem"), and the former shareholders of SmartKem, on February 23, 2021, all of the equity interests in SmartKem, except certain "deferred shares," exchanged for shares of Issuer's common stock, with SmartKem continuing as the Issuer's wholly owned subsidiary (the "Exchange"). As a condition to the Exchange, pursuant to the terms of a stock cancellation agreement, the reporting person voluntarily surrendered and canceled 50,000 shares of the Issuer's common stock prior to the consummation of the Exchange. The reporting person resigned as a director and officer of the Issuer upon consummation of the Exchange.

Read SEC document
October 05, 2020 Filed Oct 7, 2020 21:56 UTC Augmedix, Inc. NONE · Entity 86996 OtherCommon stock, par value $0.0001 per share 90,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-20-030539 · ownership.xml · nonDerivative · entry 1

Jacobs Ian Seth · CIK 0001707297 · Former Director and Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 160,000

F1 · kind: Pursuant to the terms of an Agreement and Plan of Merger and Reorganization, dated as of October 5, 2020, by and among the Issuer, August Acquisition Corp. ("Acquisition Sub"), and Augmedix Operating Company (f/k/a Augmedix, Inc.) ("Augmedix"), on October 5, 2020, Acquisition Sub merged with and into Augmedix, with Augmedix continuing as the surviving entity (the "Merger") and as the Issuer's wholly-owned subsidiary. As a condition to the Merger, pursuant to the terms of a stock cancellation agreement, the reporting person voluntarily surrendered and canceled 90,000 shares of the Issuer's common stock prior to the consummation of the Merger. The reporting person resigned as a director and officer of the Issuer upon consummation of the Merger

F1 · price: Pursuant to the terms of an Agreement and Plan of Merger and Reorganization, dated as of October 5, 2020, by and among the Issuer, August Acquisition Corp. ("Acquisition Sub"), and Augmedix Operating Company (f/k/a Augmedix, Inc.) ("Augmedix"), on October 5, 2020, Acquisition Sub merged with and into Augmedix, with Augmedix continuing as the surviving entity (the "Merger") and as the Issuer's wholly-owned subsidiary. As a condition to the Merger, pursuant to the terms of a stock cancellation agreement, the reporting person voluntarily surrendered and canceled 90,000 shares of the Issuer's common stock prior to the consummation of the Merger. The reporting person resigned as a director and officer of the Issuer upon consummation of the Merger

Read SEC document
February 12, 2020 Filed Feb 14, 2020 19:30 UTC Transphorm, Inc. NONE · Entity 15192 OtherCommon Stock, par value $0.0001 25,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-20-004042 · ownership.xml · nonDerivative · entry 1

Jacobs Ian Seth · CIK 0001707297 · Former Officer and Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 125,000

F1 · kind: Pursuant to the terms and conditions of that certain Agreement and Plan of Merger and Reorganization, dated as of February 12, 2020, by and among Transphorm, Inc., f/k/a Peninsula Acquisition Corporation (the "Issuer"), Peninsula Acquisition Sub, Inc. ("Acquisition Sub"), and Transphorm Technology, Inc., f/k/a Transphorm, Inc. ("Transphorm"), on February 12, 2020, Acquisition Sub merged with and into Transphorm, with Transphorm continuing as the surviving entity (the "Merger") and as the Issuer's wholly-owned subsidiary. Pursuant to the terms of a stock forfeiture letter, the reporting person forfeited and canceled 25,000 shares of the Issuer's common stock immediately prior to the consummation of the Merger.

F1 · price: Pursuant to the terms and conditions of that certain Agreement and Plan of Merger and Reorganization, dated as of February 12, 2020, by and among Transphorm, Inc., f/k/a Peninsula Acquisition Corporation (the "Issuer"), Peninsula Acquisition Sub, Inc. ("Acquisition Sub"), and Transphorm Technology, Inc., f/k/a Transphorm, Inc. ("Transphorm"), on February 12, 2020, Acquisition Sub merged with and into Transphorm, with Transphorm continuing as the surviving entity (the "Merger") and as the Issuer's wholly-owned subsidiary. Pursuant to the terms of a stock forfeiture letter, the reporting person forfeited and canceled 25,000 shares of the Issuer's common stock immediately prior to the consummation of the Merger.

Read SEC document
September 22, 2017 Filed Sep 26, 2017 22:05 UTC EXICURE, INC. NONE · Entity 8068 GrantCommon Stock 38,160 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-17-010015 · f4092217jacobs_max1acq.xml · nonDerivative · entry 1

Jacobs Ian Seth · CIK 0001707297 · Director · President, Secretary, CEO, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,160

F1 · price: These shares were received for services rendered in connection with a proposed merger among the issuer, Exicure, Inc., and Max-1 Acquisition Sub, Inc., a wholly owned subsidiary of the issuer.

Read SEC document
June 15, 2017 Filed Jun 19, 2017 23:40 UTC EXICURE, INC. NONE · Entity 8068 SaleCommon Stock 35,000 $0.03 $875.00
Disclosure

SEC source: 0001213900-17-006618 · f4061517jacobs_max1acq.xml · nonDerivative · entry 1

Jacobs Ian Seth · CIK 0001707297 · Director · President, Secretary, CEO, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,000

F1 · shares: The disposed shares were originally acquired from the Issuer in a transaction exempt from Section 16(b) pursuant to Rule 16b-3(d) under the Securities Exchange Act of 1934, as amended.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.